- Home
- XRN vs CLPT Comparison
XRN vs CLPT Comparison
Compare XRN & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRN | CLPT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.8M | 451.3M |
| IPO Year | 2016 | 2009 |
Fundamental Metrics
Financial Performance| Metric | XRN | CLPT |
|---|---|---|
| Price | $37.57 | $14.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 74.4K | ★ 580.5K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 8.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $4.50 | $45.67 |
| Revenue Next Year | $3.83 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $29.05 | $8.27 |
| 52 Week High | $38.65 | $30.10 |
Technical Indicators
Market Signals| Indicator | XRN | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 38.38 |
| Support Level | $34.68 | $13.38 |
| Resistance Level | $38.23 | $15.09 |
| Average True Range (ATR) | 0.96 | 0.79 |
| MACD | -0.00 | -0.46 |
| Stochastic Oscillator | 70.11 | 7.03 |
Price Performance
Historical ComparisonAbout XRN Chiron Real Estate Inc. Common Stock
Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.